| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S0007114510000851 |
| P698 | PubMed publication ID | 20420754 |
| P50 | author | Grazielle Huguenin | Q62132534 |
| P2093 | author name string | Glorimar Rosa | |
| P2860 | cites work | The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes | Q24290189 |
| Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man | Q26776977 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resi | Q31035230 | ||
| The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes | Q33899154 | ||
| Genetics of the metabolic syndrome | Q33964734 | ||
| The common PPAR-gamma2 Pro12Ala variant is associated with greater insulin sensitivity | Q34348367 | ||
| A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity | Q38331543 | ||
| Genetic variation in the peroxisome proliferator-activated receptor-gamma2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain | Q40689616 | ||
| A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity | Q43542493 | ||
| Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 gene is associated with increased antilipolytic insulin sensitivity | Q43566173 | ||
| Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians | Q43763530 | ||
| PPARgamma2 pro12Ala polymorphism and insulin resistance in Japanese hypertensive patients. | Q43940848 | ||
| Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study | Q44081023 | ||
| Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population | Q44172019 | ||
| PPAR(gamma)2 gene Pro12Ala polymorphism may influence serum level of an adipocyte-derived protein, adiponectin, in the Japanese population | Q44196997 | ||
| Differential effects of the C1431T and Pro12Ala PPARgamma gene variants on plasma lipids and diabetes risk in an Asian population | Q44210344 | ||
| Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects | Q44325204 | ||
| Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation | Q44452896 | ||
| Increased insulin clearance in peroxisome proliferator-activated receptor gamma2 Pro12Ala | Q44473943 | ||
| Prospective study of the association between the proline to alanine codon 12 polymorphism in the PPARgamma gene and type 2 diabetes | Q44599756 | ||
| Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms | Q44629006 | ||
| Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia | Q44697252 | ||
| High incidence of type 2 diabetes in peroxisome proliferator-activated receptor gamma2 Pro12Ala carriers exposed to a high chronic intake of trans fatty acids and saturated fatty acids | Q45034145 | ||
| Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2 protects against atherosclerosis | Q45050542 | ||
| Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial | Q45183730 | ||
| The effect of the Ala12 allele of the peroxisome proliferator-activated receptor-gamma2 gene on skeletal muscle glucose uptake depends on obesity: a positron emission tomography study | Q46458639 | ||
| Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus. | Q46623854 | ||
| Hyperinsulinemia is an independent predictor for complex atherosclerotic lesion of thoracic aorta in non-diabetic patients | Q46743359 | ||
| Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome | Q46824955 | ||
| Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes | Q47330796 | ||
| Clustering of cardiovascular risk factors in hyperinsulinemia in Japanese without diabetes. | Q50869061 | ||
| Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals. | Q51486794 | ||
| Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. | Q51491761 | ||
| Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity. | Q51499010 | ||
| Pro12Ala of the peroxisome proliferator-activated receptor-gamma2 gene is associated with lower serum insulin levels in nonobese African Americans: the Atherosclerosis Risk in Communities Study. | Q51536333 | ||
| The peroxisome proliferator-activated receptor-gamma2 Pro12A1a variant: association with type 2 diabetes and trait differences. | Q51549887 | ||
| Evidence for gene-nutrient interaction at the PPARgamma locus. | Q51550350 | ||
| Contribution of fasting hyperinsulinemia to prediction of atherosclerotic cardiovascular disease status in 293 hyperlipidemic patients. | Q51559659 | ||
| Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. | Q54090156 | ||
| Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations | Q57242012 | ||
| Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus | Q57605988 | ||
| The Effects of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor- 2 Gene on Glucose/Insulin Metabolism Interact With Prenatal Exposure to Famine | Q58992827 | ||
| The Pro115Gln and Pro12Ala PPAR gamma gene mutations in obesity and type 2 diabetes | Q73658806 | ||
| Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus | Q77906021 | ||
| P433 | issue | 4 | |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 488-497 | |
| P577 | publication date | 2010-04-27 | |
| P1433 | published in | British Journal of Nutrition | Q4970206 |
| P1476 | title | The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects | |
| P478 | volume | 104 |
| Q44254466 | Amerindians show no association of PPAR-γ2 gene Ala12 allele and obesity: an "unthrifty" variant population genetics |
| Q37136093 | Association between PRO12ALA polymorphism of the PPAR-γ2 gene and type 2 diabetes mellitus in Iranian patients |
| Q37567750 | Association of PPARG Pro12Ala polymorphism with insulin sensitivity and body mass index in patients with polycystic ovary syndrome |
| Q84449805 | Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with polycystic ovary syndrome: a meta-analysis |
| Q48892922 | Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population. |
| Q82274977 | Effect of interaction between PPARG, PPARA and ADIPOQ gene variants and dietary fatty acids on plasma lipid profile and adiponectin concentration in a large intervention study |
| Q26750792 | Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma |
| Q36306320 | Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARγ activation to decrease diet-induced obesity |
| Q36239731 | Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians |
| Q98164364 | PPARG (Pro12Ala) genetic variant and risk of T2DM: a systematic review and meta-analysis |
| Q92679171 | PPARγ Pro12Ala Polymorphism Influences the Relationship between Dietary Fat Intake, Adiposity and Lipid Profile in Patients with Type 2 Diabetes |
| Q35808814 | PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome |
| Q37634074 | PPARγ Pro12Ala interacts with fat intake for obesity and weight loss in a behavioural treatment based on the Mediterranean diet |
| Q34803775 | PPARγ2 Pro12Ala polymorphism was associated with favorable cardiometabolic risk profile in HIV/HCV coinfected patients: a cross-sectional study |
| Q31132059 | The association between the Pro12Ala variant in the PPARγ2 gene and type 2 diabetes mellitus and obesity in a Chinese population |
Search more.